Reoperation and Mortality after Surgical Treatment of Benign Prostatic Hypertrophy in a Large Prepaid Medical Care Program
The incidence of reoperation and mortality after prostatectomy was studied in 8,219 men who underwent surgical treatment for benign prostatic hypertrophy between 1976 and 1987 while they were members of the Kaiser Permanente Medical Care Program, Northern California Region. The vast majority (94.5%)...
Gespeichert in:
Veröffentlicht in: | Medical care 1992-02, Vol.30 (2), p.117-125 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 125 |
---|---|
container_issue | 2 |
container_start_page | 117 |
container_title | Medical care |
container_volume | 30 |
creator | Sidney, Stephen Quesenberry, Charles P. Sadler, Marianne C. Cattolica, Eugene V. Lydick, Eva G. Guess, Harry A. |
description | The incidence of reoperation and mortality after prostatectomy was studied in 8,219 men who underwent surgical treatment for benign prostatic hypertrophy between 1976 and 1987 while they were members of the Kaiser Permanente Medical Care Program, Northern California Region. The vast majority (94.5%) received transurethral prostatectomy (TURP). The cumulative 8-year probability of a second prostatectomy was 7.6% after TURP and 2.1% after open prostatectomy. The risk of mortality associated with transurethral prostatectomy relative to open prostatectomy was 1.6 (95% confidence interval 1.2, 2.1) 8 years postsurgery. The increased risk of mortality associated with transurethral prostatectomy was most prominent during the first 5 years postsurgery (relative risk 1.8, 95% confidence interval 1.3, 2.5) and declined to 1.1 (95% confidence interval 0.8, 1.6) for deaths occurring after the first 5 years. The finding of an increased risk of mortality associated with transurethral prostatectomy is consistent with other studies and is unexplained. |
doi_str_mv | 10.1097/00005650-199202000-00003 |
format | Article |
fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_72799060</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>3766055</jstor_id><sourcerecordid>3766055</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3763-278ad1986bcad41b1e07572e77bd4d47c5925883d7152a6a4afad7989a75f7333</originalsourceid><addsrcrecordid>eNp1kUFv1DAQhS1EVbaFfwCST9wCdhxn4iOsCq20iKot52g2nuymJHGwHVXLr8fblHLCF8tv5n2jeWaMS_FBCgMfRTq61CKTxuQiT6_sKKkXbCW1giQX1Uu2EiLXGQgwr9hZCPdCSFA6P2WnUkHCqBX7fUNuIo-xcyPH0fJvzkfsu3jg2Eby_Hb2u67Bnt95wjjQGLlr-Wcau93Ir70LMXkbfnlIlOjdtD_wLpH4Bv2OUgNN2CUq2UfIGv1RdDuPw2t20mIf6M3Tfc5-fLm4W19mm-9fr9afNlmjoFRZDhVaaapy26At5FaSAA05AWxtYQtotMl1VSkLUudYYoEtWjCVQdAtKKXO2fuFO3n3a6YQ66ELDfU9juTmUEMOxohSpMZqaWzSWsFTW0--G9AfainqY-z139jr59gfpeOMd08z5u1A9p9xyTnVi6X-4PqUavjZzw_k6z1hH_f1_34z2d4utvsQnX-mplxKobX6A0N1lvY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>72799060</pqid></control><display><type>article</type><title>Reoperation and Mortality after Surgical Treatment of Benign Prostatic Hypertrophy in a Large Prepaid Medical Care Program</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>JSTOR Archive Collection A-Z Listing</source><creator>Sidney, Stephen ; Quesenberry, Charles P. ; Sadler, Marianne C. ; Cattolica, Eugene V. ; Lydick, Eva G. ; Guess, Harry A.</creator><creatorcontrib>Sidney, Stephen ; Quesenberry, Charles P. ; Sadler, Marianne C. ; Cattolica, Eugene V. ; Lydick, Eva G. ; Guess, Harry A.</creatorcontrib><description>The incidence of reoperation and mortality after prostatectomy was studied in 8,219 men who underwent surgical treatment for benign prostatic hypertrophy between 1976 and 1987 while they were members of the Kaiser Permanente Medical Care Program, Northern California Region. The vast majority (94.5%) received transurethral prostatectomy (TURP). The cumulative 8-year probability of a second prostatectomy was 7.6% after TURP and 2.1% after open prostatectomy. The risk of mortality associated with transurethral prostatectomy relative to open prostatectomy was 1.6 (95% confidence interval 1.2, 2.1) 8 years postsurgery. The increased risk of mortality associated with transurethral prostatectomy was most prominent during the first 5 years postsurgery (relative risk 1.8, 95% confidence interval 1.3, 2.5) and declined to 1.1 (95% confidence interval 0.8, 1.6) for deaths occurring after the first 5 years. The finding of an increased risk of mortality associated with transurethral prostatectomy is consistent with other studies and is unexplained.</description><identifier>ISSN: 0025-7079</identifier><identifier>EISSN: 1537-1948</identifier><identifier>DOI: 10.1097/00005650-199202000-00003</identifier><identifier>PMID: 1370973</identifier><language>eng</language><publisher>United States: J. B. Lippincott-Raven Publishers</publisher><subject>Age groups ; Aged ; Aged, 80 and over ; California - epidemiology ; Confidence interval ; Death ; Humans ; Insurance, Major Medical ; Male ; Middle Aged ; Mortality ; Patient care ; Prepaid Health Plans - statistics & numerical data ; Prostatectomy ; Prostatectomy - methods ; Prostatectomy - mortality ; Prostatic hyperplasia ; Prostatic Hyperplasia - surgery ; Reoperation ; Reoperation - statistics & numerical data ; Risk ; Surgical specialties ; Transurethral resection of prostate</subject><ispartof>Medical care, 1992-02, Vol.30 (2), p.117-125</ispartof><rights>Copyright 1992 J. B. Lippincott Company</rights><rights>Lippincott-Raven Publishers.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3763-278ad1986bcad41b1e07572e77bd4d47c5925883d7152a6a4afad7989a75f7333</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/3766055$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/3766055$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,803,27923,27924,58016,58249</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1370973$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sidney, Stephen</creatorcontrib><creatorcontrib>Quesenberry, Charles P.</creatorcontrib><creatorcontrib>Sadler, Marianne C.</creatorcontrib><creatorcontrib>Cattolica, Eugene V.</creatorcontrib><creatorcontrib>Lydick, Eva G.</creatorcontrib><creatorcontrib>Guess, Harry A.</creatorcontrib><title>Reoperation and Mortality after Surgical Treatment of Benign Prostatic Hypertrophy in a Large Prepaid Medical Care Program</title><title>Medical care</title><addtitle>Med Care</addtitle><description>The incidence of reoperation and mortality after prostatectomy was studied in 8,219 men who underwent surgical treatment for benign prostatic hypertrophy between 1976 and 1987 while they were members of the Kaiser Permanente Medical Care Program, Northern California Region. The vast majority (94.5%) received transurethral prostatectomy (TURP). The cumulative 8-year probability of a second prostatectomy was 7.6% after TURP and 2.1% after open prostatectomy. The risk of mortality associated with transurethral prostatectomy relative to open prostatectomy was 1.6 (95% confidence interval 1.2, 2.1) 8 years postsurgery. The increased risk of mortality associated with transurethral prostatectomy was most prominent during the first 5 years postsurgery (relative risk 1.8, 95% confidence interval 1.3, 2.5) and declined to 1.1 (95% confidence interval 0.8, 1.6) for deaths occurring after the first 5 years. The finding of an increased risk of mortality associated with transurethral prostatectomy is consistent with other studies and is unexplained.</description><subject>Age groups</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>California - epidemiology</subject><subject>Confidence interval</subject><subject>Death</subject><subject>Humans</subject><subject>Insurance, Major Medical</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Patient care</subject><subject>Prepaid Health Plans - statistics & numerical data</subject><subject>Prostatectomy</subject><subject>Prostatectomy - methods</subject><subject>Prostatectomy - mortality</subject><subject>Prostatic hyperplasia</subject><subject>Prostatic Hyperplasia - surgery</subject><subject>Reoperation</subject><subject>Reoperation - statistics & numerical data</subject><subject>Risk</subject><subject>Surgical specialties</subject><subject>Transurethral resection of prostate</subject><issn>0025-7079</issn><issn>1537-1948</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kUFv1DAQhS1EVbaFfwCST9wCdhxn4iOsCq20iKot52g2nuymJHGwHVXLr8fblHLCF8tv5n2jeWaMS_FBCgMfRTq61CKTxuQiT6_sKKkXbCW1giQX1Uu2EiLXGQgwr9hZCPdCSFA6P2WnUkHCqBX7fUNuIo-xcyPH0fJvzkfsu3jg2Eby_Hb2u67Bnt95wjjQGLlr-Wcau93Ir70LMXkbfnlIlOjdtD_wLpH4Bv2OUgNN2CUq2UfIGv1RdDuPw2t20mIf6M3Tfc5-fLm4W19mm-9fr9afNlmjoFRZDhVaaapy26At5FaSAA05AWxtYQtotMl1VSkLUudYYoEtWjCVQdAtKKXO2fuFO3n3a6YQ66ELDfU9juTmUEMOxohSpMZqaWzSWsFTW0--G9AfainqY-z139jr59gfpeOMd08z5u1A9p9xyTnVi6X-4PqUavjZzw_k6z1hH_f1_34z2d4utvsQnX-mplxKobX6A0N1lvY</recordid><startdate>199202</startdate><enddate>199202</enddate><creator>Sidney, Stephen</creator><creator>Quesenberry, Charles P.</creator><creator>Sadler, Marianne C.</creator><creator>Cattolica, Eugene V.</creator><creator>Lydick, Eva G.</creator><creator>Guess, Harry A.</creator><general>J. B. Lippincott-Raven Publishers</general><general>Lippincott-Raven Publishers</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199202</creationdate><title>Reoperation and Mortality after Surgical Treatment of Benign Prostatic Hypertrophy in a Large Prepaid Medical Care Program</title><author>Sidney, Stephen ; Quesenberry, Charles P. ; Sadler, Marianne C. ; Cattolica, Eugene V. ; Lydick, Eva G. ; Guess, Harry A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3763-278ad1986bcad41b1e07572e77bd4d47c5925883d7152a6a4afad7989a75f7333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Age groups</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>California - epidemiology</topic><topic>Confidence interval</topic><topic>Death</topic><topic>Humans</topic><topic>Insurance, Major Medical</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Patient care</topic><topic>Prepaid Health Plans - statistics & numerical data</topic><topic>Prostatectomy</topic><topic>Prostatectomy - methods</topic><topic>Prostatectomy - mortality</topic><topic>Prostatic hyperplasia</topic><topic>Prostatic Hyperplasia - surgery</topic><topic>Reoperation</topic><topic>Reoperation - statistics & numerical data</topic><topic>Risk</topic><topic>Surgical specialties</topic><topic>Transurethral resection of prostate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sidney, Stephen</creatorcontrib><creatorcontrib>Quesenberry, Charles P.</creatorcontrib><creatorcontrib>Sadler, Marianne C.</creatorcontrib><creatorcontrib>Cattolica, Eugene V.</creatorcontrib><creatorcontrib>Lydick, Eva G.</creatorcontrib><creatorcontrib>Guess, Harry A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Medical care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sidney, Stephen</au><au>Quesenberry, Charles P.</au><au>Sadler, Marianne C.</au><au>Cattolica, Eugene V.</au><au>Lydick, Eva G.</au><au>Guess, Harry A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reoperation and Mortality after Surgical Treatment of Benign Prostatic Hypertrophy in a Large Prepaid Medical Care Program</atitle><jtitle>Medical care</jtitle><addtitle>Med Care</addtitle><date>1992-02</date><risdate>1992</risdate><volume>30</volume><issue>2</issue><spage>117</spage><epage>125</epage><pages>117-125</pages><issn>0025-7079</issn><eissn>1537-1948</eissn><abstract>The incidence of reoperation and mortality after prostatectomy was studied in 8,219 men who underwent surgical treatment for benign prostatic hypertrophy between 1976 and 1987 while they were members of the Kaiser Permanente Medical Care Program, Northern California Region. The vast majority (94.5%) received transurethral prostatectomy (TURP). The cumulative 8-year probability of a second prostatectomy was 7.6% after TURP and 2.1% after open prostatectomy. The risk of mortality associated with transurethral prostatectomy relative to open prostatectomy was 1.6 (95% confidence interval 1.2, 2.1) 8 years postsurgery. The increased risk of mortality associated with transurethral prostatectomy was most prominent during the first 5 years postsurgery (relative risk 1.8, 95% confidence interval 1.3, 2.5) and declined to 1.1 (95% confidence interval 0.8, 1.6) for deaths occurring after the first 5 years. The finding of an increased risk of mortality associated with transurethral prostatectomy is consistent with other studies and is unexplained.</abstract><cop>United States</cop><pub>J. B. Lippincott-Raven Publishers</pub><pmid>1370973</pmid><doi>10.1097/00005650-199202000-00003</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0025-7079 |
ispartof | Medical care, 1992-02, Vol.30 (2), p.117-125 |
issn | 0025-7079 1537-1948 |
language | eng |
recordid | cdi_proquest_miscellaneous_72799060 |
source | MEDLINE; Journals@Ovid Complete; JSTOR Archive Collection A-Z Listing |
subjects | Age groups Aged Aged, 80 and over California - epidemiology Confidence interval Death Humans Insurance, Major Medical Male Middle Aged Mortality Patient care Prepaid Health Plans - statistics & numerical data Prostatectomy Prostatectomy - methods Prostatectomy - mortality Prostatic hyperplasia Prostatic Hyperplasia - surgery Reoperation Reoperation - statistics & numerical data Risk Surgical specialties Transurethral resection of prostate |
title | Reoperation and Mortality after Surgical Treatment of Benign Prostatic Hypertrophy in a Large Prepaid Medical Care Program |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T06%3A42%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reoperation%20and%20Mortality%20after%20Surgical%20Treatment%20of%20Benign%20Prostatic%20Hypertrophy%20in%20a%20Large%20Prepaid%20Medical%20Care%20Program&rft.jtitle=Medical%20care&rft.au=Sidney,%20Stephen&rft.date=1992-02&rft.volume=30&rft.issue=2&rft.spage=117&rft.epage=125&rft.pages=117-125&rft.issn=0025-7079&rft.eissn=1537-1948&rft_id=info:doi/10.1097/00005650-199202000-00003&rft_dat=%3Cjstor_proqu%3E3766055%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=72799060&rft_id=info:pmid/1370973&rft_jstor_id=3766055&rfr_iscdi=true |